SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 98 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $1,450,000 | +9.1% | 203,128 | -0.3% | 0.05% | +10.2% |
Q2 2014 | $1,329,000 | -5.8% | 203,838 | -4.5% | 0.05% | -9.3% |
Q1 2014 | $1,411,000 | +38.7% | 213,433 | -0.5% | 0.05% | +38.5% |
Q4 2013 | $1,017,000 | -5.0% | 214,597 | -0.5% | 0.04% | -11.4% |
Q3 2013 | $1,070,000 | -13.3% | 215,759 | -9.4% | 0.04% | -17.0% |
Q2 2013 | $1,234,000 | – | 238,038 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |